Nodelman Oleg's Form 4 filing
Anaptysbio, Inc (ANAB) · filed May 9, 2022
- Accession no.
- 0001567619-22-009732
- Filed
- May 9, 2022, 6:04 AM ET
- Trade date
- May 5, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $14.5M. Open-market sales total $14.5M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Nodelman OlegCIK 0001454385 | Director, 10% Owner |
| EcoR1 Capital, LLCCIK 0001587114 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 5, 2022 | Common Stock | PPurchaseAcquired | +668,237 | $21.63 | +$14,453,966.31 | 7,521,024 | Indirect | |
| May 5, 2022 | Common Stock | SSaleDisposed | −668,237 | $21.63 | −$14,453,966.31 | 7,521,024 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.